Vivek Ramaswamy┬аis a New York Times bestselling author and┬аentrepreneur who has founded multiple successful enterprises. A first-generation American, he is the founder and Executive Chairman of Roivant Sciences, a new type of biopharmaceutical company focused on the application of technology to drug development.┬а He founded Roivant in 2014 and led the largest biotech IPOs of 2015 and 2016, eventually culminating in successful clinical trials in multiple disease areas that led to FDA-approved products.┬а
Mr. Ramaswamy was born and raised in southwest Ohio. He graduated┬аsumma cum laude┬аin biology from Harvard in 2007 and┬аbegan his career as a┬аbiotech investor at a prominent hedge fund. Mr. Ramaswamy continued to work as an investor while earning his law degree at Yale, where he was a recipient of the Paul and┬аDaisy Soros Fellowship for New Americans.
Mr. Ramaswamy was featured on the cover of┬аForbes┬аmagazine in 2015 for his work in drug development. In 2020 he emerged as a prominent national commentator on stakeholder capitalism, free speech, and woke culture. He has authored numerous articles and op-eds, which have appeared in the┬аWall Street Journal,┬аNational Review, Newsweek,┬аand┬аHarvard Business Review. ┬а
Mr. Ramaswamy serves on the board of directors of the Philanthropy Roundtable and the Foundation for Research on Equal Opportunity.